ENvue Medical, Inc. Stockholders Equity

Quick Answer

ENvue Medical, Inc. reported Stockholders Equity of $627.0 thousand for the year ending 2024.

  • ENvue Medical, Inc. showed a decrease of -84.3% in Stockholders Equity from 2023 to 2024.
  • This data is from ENvue Medical, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2025.
  • XBRL data for this metric is available from 2013 to 2024 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q2 2014: -$4.16 million | Q3 2014: -$4.92 million | Q1 2015: $229.0 thousand | Q2 2015: $1.47 million | Q3 2015: $505.0 thousand | Q4 2015: -$209.0 thousand | Q1 2016: -$606.0 thousand | Q2 2016: -$1.16 million | Q3 2016: -$1.60 million | Q1 2017: -$2.80 million | Q2 2017: -$3.05 million | Q3 2017: -$4.29 million | Q1 2018: $2.95 million | Q2 2018: $2.22 million | Q3 2018: $1.39 million | Q1 2019: -$469.0 thousand | Q2 2019: $1.94 million | Q3 2019: $2.23 million | Q1 2020: $498.0 thousand | Q2 2020: -$784.0 thousand | Q3 2020: $3.27 million | Q1 2021: $4.35 million | Q2 2021: $4.16 million | Q3 2021: $8.71 million | Q1 2022: $5.26 million | Q2 2022: $4.13 million | Q3 2022: $3.15 million | Q1 2023: $2.20 million | Q2 2023: $1.17 million | Q3 2023: $4.69 million | Q4 2023: $3.99 million | Q1 2024: $3.50 million | Q2 2024: $2.84 million | Q3 2024: $1.87 million | Q4 2024: $627.0 thousand | Q1 2025: $35.68 million | Q2 2025: $40.48 million | Q3 2025: $42.46 million.
  • Over the full 12 years of available data (2013 to 2024), ENvue Medical, Inc.'s Stockholders Equity has grown by 119.0%.
  • Historical annual values: Fiscal year 2024: $627.0 thousand | Fiscal year 2023: $3.99 million | Fiscal year 2022: $3.23 million | Fiscal year 2021: $6.31 million | Fiscal year 2020: $2.39 million | Fiscal year 2019: $1.35 million | Fiscal year 2018: $463.0 thousand | Fiscal year 2017: $3.63 million | Fiscal year 2016: -$2.50 million | Fiscal year 2015: -$209.0 thousand | Fiscal year 2014: -$5.62 million | Fiscal year 2013: -$3.30 million.
  • Data sourced from SEC EDGAR public filings as of August 5, 2026.

Last verified: